Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 02-Sep 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 109600801000001116 | Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 109600901000001110 | Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler | Is a | Product containing fluticasone and salmeterol | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler | Has active ingredient | Salmeterol | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler | Has active ingredient | Fluticasone | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler | VMP prescribing status (attribute) | VMP not recommended to prescribe - patient training required | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler | Has dispensed dose form | Conventional release powder for inhalation | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler | Has specific active ingredient | Fluticasone propionate | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler | Has specific active ingredient | Salmeterol xinafoate | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Salmeterol | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 500micrograms/dose / Salmeterol 50micrograms/dose dry powder inhaler | Is a | Virtual medicinal product | false | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR